Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
U.S. Senators Collins and McCaskill Release Drug Pricing Investigation…
United States Senators Susan Collins (R-ME) and Claire McCaskill (D-MO), the Chairwoman and Ranking Member of the Senate Aging…
Democrat Senators Send Letter to Trump On Drug Pricing
United States Senators Sherrod Brown (D-OH) and Al Franken (D-MN) led the charge to send a letter to President-Elect Donald Trump,…
U.S. House Introduces Updated Value-Based Incentive Legislation
The House Ways & Means Health Subcommittee recently released updated draft legislation that would establish value-based…
FDA Issues Guidance on REMS
With the passage of the long-awaited 21st Century Cures legislation, we saw Senator Mike Lee (R-UT) vote “no” because the bill did…
HHS Releases Regulations on Alternative Pay Models in Last Weeks of Current…
Despite Republicans’ call for a suspension on new rules, the Department of Health and Human Services (HHS) pushed regulations…
OIG Issues Semiannual Report to Congress
The Department of Health and Human Services (HHS) issued its Semiannual Report to Congress, covering April 1, 2016 to September…
AHR Holds Congressional Briefing Focused on Cost Growth
The Alliance for Health Reform recently held a Congressional briefing about cost growth of pharmaceuticals in the Medicare program…
Tandem Price Increases: Legal or Price Fixing?
An article by reporters at Bloomberg recently highlighted the way United States prosecutors are beginning to crack down on generic…
21st Century Bill Headed to President Obama’s Desk
Nearly three years after its initial introduction, the 21st Century Cures Act has finally passed both houses of the Congress, and…
21st Century Cures No Longer Includes Open Payments Exemption for Reprints,…
We previously wrote about the updated version of the 21st Century Cures bill – one that we, along with many others, thought would…